These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4445996)

  • 1. Progressive inactivation of purified factor VII by heparin and antithrombin III.
    Godal HC; Rygh M; Laake K
    Thromb Res; 1974 Dec; 5(6):773-5. PubMed ID: 4445996
    [No Abstract]   [Full Text] [Related]  

  • 2. The inhibition of activated bovine coagulation factors X and VII by antithrombin III.
    Jesty J
    Arch Biochem Biophys; 1978 Jan; 185(1):165-73. PubMed ID: 564164
    [No Abstract]   [Full Text] [Related]  

  • 3. INACTIVATION OF PURIFIED AUTOPROTHROMBIN I WITH ANTITHROMBIN.
    SEEGERS WH; SCHROEER H; KAGAMI M
    Can J Biochem; 1964 Oct; 42():1425-35. PubMed ID: 14240727
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of antithrombin III on the activity of the coagulation factors VII, IX and X.
    Osterud B; Miller-Andersson M; Abildgaard U; Prydz H
    Thromb Haemost; 1976 Apr; 35(2):295-304. PubMed ID: 61631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anticoagulant effect of heparin + antithrombin III using purified fibrinogen as substrate.
    Andersen P; Godal HC
    Haemostasis; 1977; 6(6):329-38. PubMed ID: 611046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of factor VIIa activity in plasma: evidence that antithrombin III is the sole plasma protease inhibitor of human factor VIIa.
    Kondo S; Kisiel W
    Thromb Res; 1987 Apr; 46(2):325-35. PubMed ID: 3496682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive inactivation of factor VII in the cold by heparin.
    Godal HC; Gravem K; Laake K
    Thromb Res; 1974 May; 4(5):707-11. PubMed ID: 4838250
    [No Abstract]   [Full Text] [Related]  

  • 8. Antithrombin-mediated inhibition of factor VIIa-tissue factor complex by the synthetic pentasaccharide representing the heparin binding site to antithrombin.
    Lormeau JC; Herault JP; Herbert JM
    Thromb Haemost; 1996 Jul; 76(1):5-8. PubMed ID: 8819242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. THE EFFECT OF HEPARIN AND EPSILON-AMINOCAPROIC ACID ON THE COAGULATION IN HYPOTHERMIC DOGS.
    JOHANSSON BW; NILSSON IM
    Acta Physiol Scand; 1964 Mar; 60():267-77. PubMed ID: 14131840
    [No Abstract]   [Full Text] [Related]  

  • 10. The anticoagulant effect in heparinized blood and plasma resulting from interactions with extrinsic pathway inhibitor.
    Lindahl AK; Abildgaard U; Staalesen R
    Thromb Res; 1991 Oct; 64(2):155-68. PubMed ID: 1811336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of heparin in the inactivation of thrombin, factor Xa, and plasmin by antithrombin III.
    Stürzebecher J; Markwardt F
    Thromb Res; 1977 Dec; 11(6):835-46. PubMed ID: 146278
    [No Abstract]   [Full Text] [Related]  

  • 12. Heparin induces release of extrinsic coagulation pathway inhibitor (EPI).
    Sandset PM; Abildgaard U; Larsen ML
    Thromb Res; 1988 Jun; 50(6):803-13. PubMed ID: 3413731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actions and interactions of antithrombin and heparin.
    Rosenberg RD
    N Engl J Med; 1975 Jan; 292(3):146-51. PubMed ID: 127943
    [No Abstract]   [Full Text] [Related]  

  • 14. Inactivation of alpha- and beta-thrombin by antithrombin-III, alpha 2-macroglobulin and alpha 1-proteinase inhibitor.
    Machovich R; Borsodi A; Blaskó G; Orakzai SA
    Biochem J; 1977 Nov; 167(2):393-8. PubMed ID: 74248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin, antithrombin, and abnormal clotting.
    Rosenberg RD
    Annu Rev Med; 1978; 29():367-78. PubMed ID: 77142
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma and serum antithrombin - III: differentiation by crossed immunoelectrophoresis.
    Sas G; Pepper DS; Cash JD
    Thromb Res; 1975 Jan; 6(1):87-91. PubMed ID: 234636
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of bovine factor IXa and factor Xabeta by antithrombin III.
    Kurachi K; Fujikawa K; Schmer G; Davie EW
    Biochemistry; 1976 Jan; 15(2):373-7. PubMed ID: 1247523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [SOME PROBLEMS OF THE ANTICOAGULANT TREATMENT OF DEEP VENOUS THROMBOSIS IN PREGNANCY].
    FORGACS J; NEMETH L
    Orv Hetil; 1964 Jun; 105():1162-5. PubMed ID: 14160767
    [No Abstract]   [Full Text] [Related]  

  • 19. Inactivation and binding of human plasma kallikrein by antithrombin III and heparin.
    Venneröd AM; Laake K; Solberg AK; Strömland S
    Thromb Res; 1976 Nov; 9(5):457-66. PubMed ID: 1087054
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacologic modulation of thrombin generation associated with human clots by human purified antithrombin alone or in the presence of low molecular weight heparin or unfractionated heparin.
    Meddahi S; Bara L; Fessi H; Samama MM
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):51-9. PubMed ID: 10691099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.